Key facts
- This page summarizes Mark K. Oki's Form 4 filing for ACHIEVE LIFE SCIENCES, INC. (ACHV).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 22 Sep 2025, 16:31.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Options Exercise
Sale
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Options Exercise
Additional SEC filing notes
Footnote F1
Represents shares of common stock acquired upon settlement of the performance restricted stock units ("PRSUs") listed in Table II.
Footnote F2
Represents shares of common stock that have been sold by the Reporting Person to satisfy income tax withholding and remittance obligations in connection with the net settlement of the PRSUs.
Footnote F3
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.83 to $3.02 per share, inclusive. The reporting person hereby undertakes to provide to the Issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Footnote F4
Each PRSU represents a contingent right to receive one share of the issuer's common stock at settlement.
Footnote F5
Pursuant to the terms of the award agreement governing the PRSU, the total number of shares underlying the PRSU vest on the achievement of one of certain milestones.